Vertex Pharmaceuticals Inc. buy Wells Fargo & Company
Start price
06.02.24
/
50%
€383.95
Target price
06.02.25
€502.09
Performance (%)
21.15%
End price
07.02.25
€465.15
Summary
This prediction ended on 07.02.25 with a price of €465.15. The prediction had a final performance of 21.15%. Wells_Fargo___Compan has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 1.155% | 1.155% | 2.324% |
| iShares Core DAX® | 0.299% | 4.557% | 21.480% |
| iShares Nasdaq 100 | 0.666% | 2.752% | 6.184% |
| iShares Nikkei 225® | -0.656% | 0.000% | 13.889% |
| iShares S&P 500 | 0.352% | 1.854% | 3.566% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Wells Fargo & Company from $500.00 to $540.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Wells_Fargo___Compan for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€398.50
10.01.25
10.01.25
€447.72
10.01.26
10.01.26
-2.55%
19:34
19:34
Stopped prediction by Wells_Fargo___Compan for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€380.75
10.12.25
10.12.25
€442.18
10.12.26
10.12.26
2.00%
19:34
19:34
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€325.60
06.08.25
06.08.25
€397.62
06.08.26
06.08.26
19.27%
19:34
19:34
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€439.95
24.06.24
24.06.24
€516.65
24.06.25
24.06.25
-11.44%
25.06.25
25.06.25